Are you Dr. Kolhe?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 13 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1120 15th St
Augusta, GA 30912Phone+1 706-721-5118
Summary
- Dr. Ravindra Kolhe, MD is a board certified pathologist in Augusta, Georgia. He is currently licensed to practice medicine in Georgia. He is affiliated with WellStar MCG Health, affiliated with Medical College of Georgia.
Education & Training
- Medical College of GeorgiaResidency, Pathology-Anatomic and Clinical, 2008 - 2012
- Mahatma Gandhi Missions Medical CollegeClass of 2001
Certifications & Licensure
- GA State Medical License 2012 - 2025
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 157 citationsGender-specific differential expression of exosomal miRNA in synovial fluid of patients with osteoarthritisRavindra Kolhe, Monte Hunter, Siyang Liu, Ravirajsinh N. Jadeja, Chetan Pundkar
Scientific Reports. 2017-05-17 - 67 citationsStem Cell-Derived Exosomes: A Potential Alternative Therapeutic Agent in OrthopaedicsJohn Burke, Ravindra Kolhe, Monte Hunter, Carlos Isales, Mark W. Hamrick
Stem Cells International. 2016-01-19 - 18 citationsNatural Killer Cells and Dendritic Cells: Expanding Clinical Relevance in the Non-Small Cell Lung Cancer (NSCLC) Tumor Microenvironment.Pankaj Ahluwalia, Meenakshi Ahluwalia, Ashis K. Mondal, Nikhil Shri Sahajpal, Vamsi Kota
Cancers. 2021-08-11
Press Mentions
- Optimal Genome Mapping Offers High-Resolution Method to Better See, Then Target Cancer-Causing Gene Variants — ScienceDailyJanuary 18th, 2023
- Optimal Genome Mapping Offers High-Resolution Method to Better See, Then Target Cancer-Causing Gene VariantsJanuary 17th, 2023
- Scientists at Augusta University Examine Link Between Genetics and COVID-19 RiskFebruary 3rd, 2022
- Join now to see all